Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Development of a Novel Functional Eye-Tracking Software Application for Multiple Sclerosis

NCT: NCT05061953 · RECRUITING

NCT IDNCT05061953
StatusRECRUITING
Start Date2021-10-18
Completion2027-10-18

Brief Summary

This study aims to develop and validate a sensitive and non-invasive eye-tracking software application. This study will obtain participant responses to brief cognitive tests designed to evaluate several key functions known to be affected by MS and non-invasive eye movement measurements in response to visually presented stimuli during specifically designed eye-tracking tests. The study data will be used to develop machine learning algorithms and validate a software application intended to track the progressive component of multiple sclerosis and associated cognitive changes.

Frequently Asked Questions

What is Development of a Novel Functional Eye-Tracking Software Application for Multiple Sclerosis?

Development of a Novel Functional Eye-Tracking Software Application for Multiple Sclerosis is a clinical trial registered under NCT05061953. Current status: RECRUITING.

What is the status of NCT05061953?

The current status of NCT05061953 (Development of a Novel Functional Eye-Tracking Software Application for Multiple Sclerosis) is: RECRUITING.

When did Development of a Novel Functional Eye-Tracking Software Application for Multiple Sclerosis start?

Development of a Novel Functional Eye-Tracking Software Application for Multiple Sclerosis started on 2021-10-18.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.